Building durable value, quarter after quarter.

Financial results, filings, governance, and shareholder resources for Sharon AI, Inc. (NASDAQ: SHAZ).

First Quarter 2026 Results

Reported May 15, 2026

NASDAQ: SHAZ

$79.96

USD

Prices are updated daily at market close
July 6, 2026 · 4:00 PM ET

Financial Info

Quarterly Results

First Quarter 2026

Press Releases & News

NVIDIA Strategic Compute Collaboration

Last updated:

June 17, 2026

1 / 1

Sharon AI Investor Deck

Last updated:

May 15, 2026

1 / 1

SEC Filings

From
-
To
|
Filing date Type Description View
Jul 2, 2026 PRE 14A Form PRE 14A - Other preliminary proxy statements
Jul 2, 2026 4 Form 4 - Statement of changes in beneficial ownership of securities
Jun 30, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Jun 30, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Jun 30, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Jun 30, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Jun 29, 2026 SCHEDULE 13G Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 29, 2026 3 Form 3 - Initial statement of beneficial ownership of securities
Jun 29, 2026 8-K Form 8-K - Current report - Item 7.01 Item 9.01
Jun 26, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Jun 26, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Jun 26, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Jun 25, 2026 8-K Form 8-K - Current report - Item 1.01 Item 2.03 Item 3.02 Item 9.01
Jun 17, 2026 8-K/A Form 8-K/A - Current report: [Amend] - Item 1.01 Item 2.03 Item 3.02 Item 7.01 Item 9.01
Jun 17, 2026 8-K Form 8-K - Current report - Item 1.01 Item 2.03 Item 3.02 Item 7.01 Item 9.01
Jun 15, 2026 8-K Form 8-K - Current report - Item 7.01 Item 9.01
Jun 12, 2026 8-K Form 8-K - Current report - Item 7.01 Item 9.01
Jun 12, 2026 8-K Form 8-K - Current report - Item 3.02
Jun 12, 2026 EFFECT Form EFFECT - Notice of Effectiveness
Jun 11, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Jun 5, 2026 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933
May 22, 2026 4 Form 4 - Statement of changes in beneficial ownership of securities
May 22, 2026 3 Form 3 - Initial statement of beneficial ownership of securities
May 22, 2026 8-K Form 8-K - Current report - Item 1.01 Item 5.02 Item 7.01 Item 9.01
May 21, 2026 8-K Form 8-K - Current report - Item 1.01 Item 2.03 Item 3.02 Item 7.01 Item 9.01
May 15, 2026 10-Q Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2026 SCHEDULE 13G Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 14, 2026 8-K Form 8-K - Current report - Item 7.01 Item 9.01
May 6, 2026 8-K Form 8-K - Current report - Item 1.01 Item 1.02 Item 5.02 Item 9.01
May 4, 2026 3 Form 3 - Initial statement of beneficial ownership of securities
May 1, 2026 D Form D - Notice of Exempt Offering of Securities - Item 06b
Apr 29, 2026 8-K Form 8-K - Current report - Item 7.01 Item 9.01
Apr 28, 2026 8-K Form 8-K - Current report - Item 1.01 Item 2.03 Item 3.02 Item 7.01 Item 9.01
Apr 22, 2026 EFFECT Form EFFECT - Notice of Effectiveness
Apr 21, 2026 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
Apr 20, 2026 POS AM Form POS AM - Post-Effective amendments for registration statement
Apr 17, 2026 POS AM Form POS AM - Post-Effective amendments for registration statement
Apr 15, 2026 SCHEDULE 13G Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 13, 2026 8-K Form 8-K - Current report - Item 7.01 Item 9.01
Apr 13, 2026 8-K Form 8-K - Current report - Item 8.01
Apr 13, 2026 8-K Form 8-K - Current report - Item 8.01 Item 9.01
Apr 13, 2026 SCHEDULE 13D Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Apr 8, 2026 SCHEDULE 13D Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Apr 1, 2026 8-K Form 8-K - Current report - Item 1.01 Item 7.01 Item 9.01
Mar 31, 2026 8-K Form 8-K - Current report - Item 7.01 Item 9.01
Mar 31, 2026 10-K Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2026 SCHEDULE 13D Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Mar 25, 2026 4 Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2026 4 Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2026 3 Form 3 - Initial statement of beneficial ownership of securities

Annual Reports

FY2025 - Annual Report

Corporate Governance

HR Policy - Diversity and Inclusion

Ethical standards and practices that promote a diverse, inclusive, and equitable workplace.

HR Policy - Whistleblower Rights and Protections Policy

Safeguards for employees to report concerns in good faith without fear of retaliation.

Audit and Risk Management Committee Charter

Responsibilities and authority of the Committee overseeing audit integrity and key risks.

Board Charter

Roles, responsibilities, and governance framework for the SHARON AI Board of Directors.

Bribery Corruption and Fraud Policy

Zero‑tolerance standards and controls to prevent bribery, corruption, and fraudulent conduct.

Code of Ethics and Business Conduct

Ethical standards guiding directors, officers, and employees in all business activities.

Compensation Committee Charter

Mandate and principles for overseeing executive and employee compensation programs.

Corporate Governance and Nominating Committee Charter

Duties for Board composition, director nominations, and ongoing governance oversight.

Disclosure Policy

Principles for accurate, timely, and transparent public disclosure of company information.

Insider Trading Policy

Standards governing trading in SHAZ securities by directors, officers, and employees.

Stockholder Communication Policy

Framework for transparent, consistent communication with SHARON AI stockholders.

Related Party Transactions Policy

Controls and approval processes for transactions involving related parties.

Share Registries

Australia - Automic Group

United States - Continental Stock Transfer and Trust

Annual General Meeting

2025 Annual Meeting of Stockholders

Investor Relations Contact

For analyst inquiries, media requests, and institutional investor communications.

Address, Australia

Level 1
32 Walker St
North Sydney, NSW 2060

Address, United States

745 5th Avenue
Suite 500
New York, NY 10151

We aim to respond to all investor enquiries within 2 business days.
×
By clicking the "submit" button, you agree to and accept our Terms & Conditions and Privacy Policy .
×
By clicking the "submit" button, you agree to and accept our Terms & Conditions and Privacy Policy .
×
By clicking the "submit" button, you agree to and accept our Terms & Conditions and Privacy Policy .
×
By clicking the "submit" button, you agree to and accept our Terms & Conditions and Privacy Policy .